| |
| Issue |
Title |
| |
| Vol 2, No 3 (2022) |
ISONIAZID-INDUCED LIVER INJURY: PHARMACOGENETIC ASPECTS |
Abstract
PDF (Rus)
|
|
N. M. Krasnova, V. M. Nikolaev |
| |
| Vol 2, No 3 (2022) |
POLYMORPHISMS RS1004467 AND RS11191548 AT CYP17A1 ARE ASSOCIATED WITH EARLY HYPOLIPIDEMIC RESPONSE TO ROSUVASTATIN THERAPY |
Abstract
PDF (Rus)
|
|
S. I. Kononov, Y. E. Azarova, E. Y. Klyosova, M. A. Bykanova, I. N. Kononova, A. V. Polonikov |
| |
| Vol 2, No 3 (2022) |
PHARMACOGENETIC TESTING AS AN ELEMENT OF PERSONALIZED MEDICINE IN REAL CLINICAL PRACTICE |
Abstract
PDF (Rus)
|
|
A. S. Barteneva, N. A. Vorobyeva |
| |
| 1 - 3 of 3 Items |
|
